. DAPT and RO4929097 effectively inhibit Notch signaling without altering cell viability. (A,B) Measurement of HUVEC (A) and hLEC (B) cell viability after GSI treatments. Quantitative data are represented as mean ± SEM. n = 3 for HUVEC and hLEC. Significance was determined by 2-tailed, type 2 Student's t test, *P < 0.05. (C,D) Relative expression of downstream Notch target gene Hey1 in GSI-treated HUVEC (C) and hLEC (D) . Quantitative data are represented as mean values of fold change over DMSO control ± SEM. n = 4 for each cell line. Gapdh and β-actin were used as housekeeping control. Significance was determined by 2-tailed, type 2 Student's t test, *P < 0.05, **P < 0.01.
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(2020) 10:1847 | https://doi.org/10.1038/s41598-020-58751-8 www.nature.com/scientificreports www.nature.com/scientificreports/ In Figure 6 , several duplicate images were inadvertently introduced, and the concentrations listed are incorrect. A re-analyzed and re-assembled Figure 6 , with the correct information, is provided below as Figure 2 .
As a result, in the Results section under subheading "γ-secretase inhibitors can effectively inhibit angiogenesis of both human blood and lymphatic cultured endothelial cells", "8 μM of DAPT reduced hLEC migration to about 50% and HUVEC migration to about 35% while RO4929097 was more effective at 6 μM in both cell types ( Fig. 6C ,D)". should read:
"30 μM of DAPT reduced hLEC migration by 90% and HUVEC migration by about 50%; HUVEC migration was significantly reduced at 2 μM. RO4929097 had significant effect on hLEC starting 30 μM and 10 μM on HUVECs ( And under the subheading "Scratch migration assay", "After scratching, the wells were rinsed with 1XPBS to remove non-adherent cells and then treated with control DMSO or increasing concentrations [2, 4, 6, 8, 10, 20 μM] of DAPT or RO4929097" should read:
"After scratching, the wells were rinsed with 1XPBS to remove non-adherent cells and then treated with control DMSO or increasing concentrations [2, 5, 10, 20, 30, 40 μM] of DAPT or RO4929097"
The main conclusions of the Article are unaffected by these changes.
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